Clinical Trial Update: Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms. [Phase 3]

View source ↗

Summary

A Phase 3 safety and efficacy trial evaluating a drospirenone/estradiol combination for vasomotor symptoms in postmenopausal Chinese women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Vasomotor Symptoms

Drugs mentioned

• Drospirenone/estradiol (Drospirenone and Estradiol)

Snippet

Sponsor: Bayer | Conditions: Vasomotor Symptoms | Phase 3 | Status: COMPLETED